<DOC>
	<DOCNO>NCT00990132</DOCNO>
	<brief_summary>This study design investigate effect home mechanical ventilation ( HMV ) patient severe chronic obstructive pulmonary disease ( COPD ) . The purpose trial test hypothesis HMV longterm oxygen therapy ( LTOT ) increase admission free survival compare LTOT alone . More specifically , compare LTOT , HMV LTOT reduce hospital re-admission COPD patient remain persistently hypercapnic follow acute exacerbation require non-invasive ventilation ( NIV ) .</brief_summary>
	<brief_title>Home Mechanical Ventilation v Home Oxygen Therapy COPD</brief_title>
	<detailed_description>Although HMV show improve physiological parameter well clinical benefit term dyspnoea exercise capacity severe COPD , publish randomise controlled trial less positive . The Steering Committee commit design robust clinical trial answer clinical question . Therefore , multi-centre randomise control trial design recruitment power calculation base applicant data . We recruit 8 UK university centre expertise HMV , 116 hypercapnic patient ( 58 arm ) persistent hypercapnia follow episode acute hypercapnic respiratory failure . During acute hypercapnic episode patient would eligible non-invasive ventilation pH &lt; 7.35 partial pressure carbon dioxide ( PaCO2 ) &gt; 7.0kPa . They randomise , 12 month , either 1 . HMV LTOT ( Treatment Group ) 2 . LTOT alone ( Control Group ) This study would allow investigator answer number question pertain clinical efficacy HMV COPD well mechanism action HMV COPD - Does HMV effect admission-free survival ? - Does HMV reduce exacerbation frequency ? - Does HMV impact disease progression ? - Does HMV improve health-related quality life ? - Does HMV improve exercise capacity ? - Is dose-response hour ventilator compliance daytime PaO2 PaCO2 ? - Do patient increase hour ventilator use acute exacerbation ? - Is ventilator compliance HMV LTOT acceptable ? - Does HMV reduce healthcare utilisation ? Follow-up assessment perform 6 week , 3 , 6 12 month . These data collect include admission-free survival ( primary outcome ) , hour compliance HMV , HRQL , gas exchange , lung function , body composition , exercise capacity , exacerbation frequency primary care consultation compliance LTOT , time withdrawal LTOT/night-time oxygen therapy base daytime PaO2 overnight SaO2 ( secondary outcome measure ) . The relation change factor predict severity COPD study . The cost effectiveness cost-utility analysis HMV study .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Patients COPD Acute hypercapnic exacerbation COPD least 2 week previously Tolerated noninvasive ventilation acute hypercapnic exacerbation Chronic hypoxia require LTOT ( PaO2 &lt; 7.3kPa PaO2 &gt; 7.3 &lt; 8.0kPa one following : secondary polycythaemia ; nocturnal hypoxaemia SaO2 &lt; 90 % &gt; 30 % time ; peripheral oedema ; PHT ) Chronic hypercapnia ( PaCO2 &gt; 7kPa ) â‰¥20 pack year smoke history FEV1/FVC &lt; 60 % FEV1 &lt; 50 % predict Persistent hypercapnic respiratory failure acidosis ( define pH &lt; 7.30 bronchodilator ) Development worsen hypercapnic respiratory failure acidosis initiation LTOT therapy Failure tolerate NIV acute illness precede trial identification Post extubation decannulation follow AHRF require intubation Restrictive lung disease cause hypercapnia i.e . obesity hypoventilation chest wall disease , however patient include FEV1/FVC ratio &lt; 60 % FEV1 &lt; 50 % predominant defect consider obstructive center clinician . Clinical feature severe OSA BMI &gt; 35kg/m2 Unstable coronary artery syndrome Cognitive impairment would prevent informed consent trial Psychiatric disease necessitate antipsychotic medication , ongoing treatment drug alcohol addiction , person fix abode postdischarge Patients undergoing renal replacement therapy Age &lt; 18 year Pregnant Inability comply protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>Respiratory failure</keyword>
	<keyword>Non-invasive ventilation</keyword>
	<keyword>Home mechanical ventilation</keyword>
</DOC>